CUTISS

Description

CUTISS develops denovoSkin™, a personalized living skin tissue therapy for patients requiring skin surgery, and uses in-house GMP manufacturing plus a patented closed automation platform for scalable production across burns, reconstructive, and aesthetic applications.

CUTISS is located in the Zurich ecosystem.

Related

• Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…
• CellabCellab CDMO provides development and GMP manufacturing services for advanced therapy medicinal products.
• KerecisKerecis develops, manufactures, and distributes fish-skin medical devices that use intact fish skin and fatty acids as a scaffold for cell…
• CCeraVxCeraVx develops ceramic CeraMaps microneedle patches for intradermal delivery of vaccines and medicines, using biocompatible, inert…
• CFM PharmaCFM Pharma is a Dutch clinical-stage biotech developing VANADIS®, a platform for tissue protection and repair in acute injury, with…
• LEO PharmaLEO Pharma develops and delivers innovative treatments for medical dermatology, producing medicines and supplying healthcare providers and…
• Nia HealthNia Health develops indication-specific medical software platforms that deliver personalized digital therapeutics combining clinical…
• RehaptixRehaptix provides touchscreen-based rehabilitation tests that measure upper-limb impairments, show immediate results, and let patients…
• Origin by OceanOrigin by Ocean converts invasive Sargassum into separated ingredient families—fucoidan and alginate—using a biorefinery platform to…